Tissue-specific glucocorticoid action: a family affair

Trends in Endocrinology and Metabolism

Volumn 19, Issue 9, 2008, Pages 331-339

  Gross, Katherine L ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HYDROCORTISONE; MIFEPRISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ALTERNATIVE RNA SPLICING; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BINDING SITE; CARDIOVASCULAR RISK; DNA BINDING; DNA POLYMORPHISM; HUMAN; LEUKEMIA; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RNA TRANSLATION; UNSPECIFIED SIDE EFFECT;

GLUCOCORTICOIDS; HUMANS; MODELS, BIOLOGICAL; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 53849143575     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.07.009     Document Type: Review

References (78)

1. Smith S.M., and Vale W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 8 (2006) 383-395
2. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353 (2005) 1711-1723
3. Styczynski J., et al. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia. Anticancer Res. 25 (2005) 2253-2258
4. Bachmann P.S., et al. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res. 67 (2007) 4482-4490
5. Lewis-Tuffin L.J., and Cidlowski J.A. The physiology of human glucocorticoid receptor β (hGRβ) and glucocorticoid resistance. Ann. N. Y. Acad. Sci. 1069 (2006) 1-9
6. Viegas L.R., et al. Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids. J. Steroid Biochem. Mol. Biol. 109 (2008) 273-278
7. Keith B.D. Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy. BMC Cancer 8 (2008) 84
8. Mazziotti G., et al. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab. 17 (2006) 144-149
9. Rosen J., and Miner J.N. The search for safer glucocorticoid receptor ligands. Endocr. Rev. 26 (2005) 452-464
10. Torpy D.J., and Ho J.T. Corticosteroid-binding globulin gene polymorphisms: clinical implications and links to idiopathic chronic fatigue disorders. Clin. Endocrinol. (Oxf.) 67 (2007) 161-167
11. Whitworth J.A., et al. Cardiovascular consequences of cortisol excess. Vasc. Health Risk Manag. 1 (2005) 291-299
12. Walker B.R., and Andrew R. Tissue production of cortisol by 11β-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann. N. Y. Acad. Sci. 1083 (2006) 165-184
13. Morton N.M., and Seckl J.R. 11β-hydroxysteroid dehydrogenase type 1 and obesity. Front. Horm. Res. 36 (2008) 146-164
14. Naray-Fejes-Toth A., and Fejes-Toth G. Novel mouse strain with Cre recombinase in 11β-hydroxysteroid dehydrogenase-2-expressing cells. Am. J. Physiol. Renal Physiol. 292 (2007) F486-F494
15. Seckl J.R., and Walker B.R. 11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol. Metab. 15 (2004) 418-424
16. Andres J., et al. Cell-type specific regulation of the human 11β-hydroxysteroid dehydrogenase type 1 promoter. Arch. Physiol. Biochem. 113 (2007) 110-115
17. De Sousa Peixoto R.A., et al. Preadipocyte 11β-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo. Endocrinology 149 (2008) 1861-1868
18. Bhat B.G., et al. Antisense inhibition of 11βhydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model. Biochem. Biophys. Res. Commun. 365 (2008) 740-745
19. Paterson J.M., et al. Metabolic syndrome without obesity: hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7088-7093
20. Kershaw E.E., et al. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54 (2005) 1023-1031
21. Desbriere R., et al. 11β-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 14 (2006) 794-798
22. Engeli S., et al. Regulation of 11β-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes. Res. 12 (2004) 9-17
23. Paulsen S.K., et al. 11β-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 15 (2007) 1954-1960
24. Sandeep T.C., et al. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54 (2005) 872-879
25. Yang H., et al. Discovery of novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling. Bioorg. Med. Chem. Lett. 18 (2008) 1340-1345
26. Lu N.Z., et al. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol. Rev. 58 (2006) 782-797
27. Chrousos G.P., and Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE 2005 (2005) pe48
28. Pratt W.B., et al. Chaperoning of glucocorticoid receptors. Handb. Exp. Pharmacol. (2006) 111-138
29. Ratajczak T., et al. Immunophilin chaperones in steroid receptor signalling. Curr. Top. Med. Chem. 3 (2003) 1348-1357
30. Freedman N.D., and Yamamoto K.R. Importin 7 and importin α/importin β are nuclear import receptors for the glucocorticoid receptor. Mol. Biol. Cell 15 (2004) 2276-2286
31. Dostert A., and Heinzel T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr. Pharm. Des. 10 (2004) 2807-2816
32. Carpentier R., et al. The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1. J. Neurochem. 104 (2008) 777-789
33. Tronche F., et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 18 (2004) 492-497
34. De Bosscher K., et al. The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24 (2003) 488-522
35. Bhavsar P.K., et al. Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-κB. Faseb J (2008)
36. Novac N., et al. Competition between glucocorticoid receptor and NFκB for control of the human FasL promoter. FASEB J. 20 (2006) 1074-1081
37. Widen C., et al. Cytosolic glucocorticoid receptor interaction with nuclear factor-κ B proteins in rat liver cells. Biochem. J. 373 (2003) 211-220
38. Cuzzocrea S., et al. Peroxisome proliferator-activated receptor-α contributes to the anti-inflammatory activity of glucocorticoids. Mol. Pharmacol. 73 (2008) 323-337
39. Lu N.Z., et al. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell. Biol. 27 (2007) 7143-7160
40. Song I.H., and Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol. Cell. Endocrinol. 246 (2006) 142-146
41. Lowenberg M., et al. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73 (2008) 1025-1029
42. Lowenberg M., et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep. 7 (2006) 1023-1029
43. Yudt M.R., et al. Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol. Cell. Biol. 23 (2003) 4319-4330
44. Fruchter O., et al. The human glucocorticoid receptor (GR) isoform β differentially suppresses GRα-induced transactivation stimulated by synthetic glucocorticoids. J. Clin. Endocrinol. Metab. 90 (2005) 3505-3509
45. Charmandari E., et al. The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes. Mol. Endocrinol. 19 (2005) 52-64
46. Lewis-Tuffin L.J., et al. Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol. Cell. Biol. 27 (2007) 2266-2282
47. Kelly A., et al. The glucocorticoid receptor β isoform can mediate transcriptional repression by recruiting histone deacetylases. J. Allergy Clin. Immunol. 121 (2008) 203-208
48. Tliba O., et al. CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-α and interferon-γ by a mechanism involving the up-regulation of the glucocorticoid receptor β isoform. Mol. Pharmacol. 69 (2006) 588-596
49. Goecke I.A., et al. Methotrexate regulates the expression of glucocorticoid receptor α and β isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Mol. Immunol. 44 (2007) 2115-2123
50. Torrego A., et al. Glucocorticoid receptor isoforms α and β in in vitro cytokine-induced glucocorticoid insensitivity. Am. J. Respir. Crit. Care Med. 170 (2004) 420-425
51. Koga Y., et al. Differential mRNA expression of glucocorticoid receptor α and β is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediatr. Blood Cancer 45 (2005) 121-127
52. Piotrowski P., et al. Glucocorticoid receptor β splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem. Cytobiol. 45 (2007) 339-342
53. Haarman E.G., et al. Glucocorticoid receptor α, β and γ expression vs in vitro glucocorticod resistance in childhood leukemia. Leukemia 18 (2004) 530-537
54. Tissing W.J., et al. Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia. Haematologica 90 (2005) 1279-1281
55. Choi B.R., et al. Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps. Exp. Mol. Med. 38 (2006) 466-473
56. Hausmann M., et al. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD. Gut 56 (2007) 1328-1329
57. Matsubara T., et al. Reduced glucocorticoid receptor α expression in mood disorder patients and first-degree relatives. Biol. Psychiatry 59 (2006) 689-695
58. Perlman W.R., et al. Reduced glucocorticoid and estrogen receptor α messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 56 (2004) 844-852
59. van den Akker E.L., et al. Glucocorticoid receptor gene and risk of cardiovascular disease. Arch. Intern. Med. 168 (2008) 33-39
60. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18 (2005) 331-342
61. Duma D., et al. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102 (2006) 11-21
62. Derijk R.H., and de Kloet E.R. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur. J. Pharmacol. 583 (2008) 303-311
63. Russcher H., et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 90 (2005) 5804-5810
64. Russcher H., et al. Increased expression of the glucocorticoid receptor-α translational isoform as a result of the ER22/23EK polymorphism. Mol. Endocrinol. 19 (2005) 1687-1696
65. Tissing W.J., et al. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin. Cancer Res. 11 (2005) 6050-6056
66. van Rossum E.F., and Lamberts S.W. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 59 (2004) 333-357
67. van Rossum E.F., et al. Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. Am. J. Med. 117 (2004) 158-162
68. Syed A.A., et al. Association of glucocorticoid receptor polymorphism A3669G in exon 9β with reduced central adiposity in women. Obesity (Silver Spring) 14 (2006) 759-764
69. van den Akker E.L., et al. Glucocorticoid receptor polymorphism affects transrepression but not transactivation. J. Clin. Endocrinol. Metab. 91 (2006) 2800-2803
70. van den Akker E.L., et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J. Infect. Dis. 194 (2006) 814-818
71. Jewell C.M., and Cidlowski J.A. Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. J. Clin. Endocrinol. Metab. 92 (2007) 3268-3277
72. Di Blasio A.M., et al. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. (Oxf.) 59 (2003) 68-74
73. Lin R.C., et al. Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41 (2003) 404-407
74. Rosmond R. Glucocorticoid receptor gene and coronary artery disease: right idea, wrong gene variant?. Hypertension 42 (2003) e3-e4
75. Boyle B., et al. Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy. Br. J. Ophthalmol. 92 (2008) 131-134
76. Syed A.A., et al. A common intron 2 polymorphism of the glucocorticoid receptor gene is associated with insulin resistance in men. Clin. Endocrinol. (Oxf) 68 (2008) 879-884
77. van Rossum E.F., et al. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin. Endocrinol. (Oxf.) 61 (2004) 573-581
78. Lu N.Z., and Cidlowski J.A. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 16 (2006) 301-307